Synovus Financial’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-31,847
| Closed | -$70.1K | – | 923 |
|
2025
Q1 | $70.1K | Hold |
31,847
| – | – | ﹤0.01% | 883 |
|
2024
Q4 | $48.7K | Hold |
31,847
| – | – | ﹤0.01% | 867 |
|
2024
Q3 | $63.4K | Hold |
31,847
| – | – | ﹤0.01% | 905 |
|
2024
Q2 | $111K | Buy |
+31,847
| New | +$111K | ﹤0.01% | 827 |
|
2020
Q3 | – | Sell |
-130
| Closed | -$2K | – | 1007 |
|
2020
Q2 | $2K | Sell |
130
-470
| -78% | -$7.23K | ﹤0.01% | 1428 |
|
2020
Q1 | $8K | Buy |
600
+470
| +362% | +$6.27K | ﹤0.01% | 1623 |
|
2019
Q4 | $3K | Hold |
130
| – | – | ﹤0.01% | 1374 |
|
2019
Q3 | $2K | Hold |
130
| – | – | ﹤0.01% | 1387 |
|
2019
Q2 | $2K | Hold |
130
| – | – | ﹤0.01% | 1318 |
|
2019
Q1 | $3K | Hold |
130
| – | – | ﹤0.01% | 1299 |
|
2018
Q4 | $3K | Hold |
130
| – | – | ﹤0.01% | 1268 |
|
2018
Q3 | $4K | Buy |
+130
| New | +$4K | ﹤0.01% | 1259 |
|